Conatus Pharmaceuticals Inc (CNAT):企業の財務・戦略的SWOT分析

◆英語タイトル:Conatus Pharmaceuticals Inc (CNAT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15006
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Conatus Pharmaceuticals Inc (Conatus) is a biotechnology company that develops and commercializes novel medicines for the treatment of liver diseases. The company’s lead pipeline candidate includes emricasan, an orally active pan-caspase protease inhibitor which is designed to reduce the activity of human caspases and is intended for the treatment of various indications such as post-orthotopic liver transplant, nonalcoholic steatohepatitis (NASH) cirrhosis and NASH fibrosis. Its other preclinical product candidates include IDN-7314, a pan-caspase inhibitor intended for the treatment of primary sclerosing cholangitis; and others. Conatus is headquartered in San Diego, California, the US.

Conatus Pharmaceuticals Inc Key Recent Developments

Jan 28,2019: Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
Nov 08,2018: Conatus Pharmaceuticals Announces Presentations and Posters at AASLD Annual Meeting
Nov 01,2018: Conatus Pharmaceuticals reports third quarter 2018 financial results and program updates
Aug 01,2018: Conatus Pharmaceuticals Reports Second Quarter 2018 Financial Results and Program Updates
May 02,2018: Conatus Pharmaceuticals Reports First Quarter 2018 Financial Results and Program Updates

This comprehensive SWOT profile of Conatus Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Conatus Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Conatus Pharmaceuticals Inc – Key Information
Conatus Pharmaceuticals Inc – Overview
Conatus Pharmaceuticals Inc – Key Employees
Conatus Pharmaceuticals Inc – Key Employee Biographies
Conatus Pharmaceuticals Inc – Key Operational Heads
Conatus Pharmaceuticals Inc – Major Products and Services
Conatus Pharmaceuticals Inc – History
Conatus Pharmaceuticals Inc – Company Statement
Conatus Pharmaceuticals Inc – Locations And Subsidiaries
Conatus Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Conatus Pharmaceuticals Inc – Business Description
Conatus Pharmaceuticals Inc – Corporate Strategy
Conatus Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Conatus Pharmaceuticals Inc – Strengths
Conatus Pharmaceuticals Inc – Weaknesses
Conatus Pharmaceuticals Inc – Opportunities
Conatus Pharmaceuticals Inc – Threats
Conatus Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Conatus Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Conatus Pharmaceuticals Inc, Key Information
Conatus Pharmaceuticals Inc, Key Ratios
Conatus Pharmaceuticals Inc, Share Data
Conatus Pharmaceuticals Inc, Major Products and Services
Conatus Pharmaceuticals Inc, History
Conatus Pharmaceuticals Inc, Key Employees
Conatus Pharmaceuticals Inc, Key Employee Biographies
Conatus Pharmaceuticals Inc, Key Operational Heads
Conatus Pharmaceuticals Inc, Other Locations
Conatus Pharmaceuticals Inc, Subsidiaries
Conatus Pharmaceuticals Inc, Key Manufacturing facilities
Conatus Pharmaceuticals Inc, Key Competitors
Conatus Pharmaceuticals Inc, SWOT Analysis
Conatus Pharmaceuticals Inc, Ratios based on current share price
Conatus Pharmaceuticals Inc, Annual Ratios
Conatus Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Conatus Pharmaceuticals Inc, Performance Chart
Conatus Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Conatus Pharmaceuticals Inc (CNAT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cimarex Energy Co (XEC)-石油・ガス分野:企業M&A・提携分析
    Summary Cimarex Energy Co. (Cimarax) is an independent upstream oil and natural gas company. It carries out the exploration and production of crude oil, natural gas and natural gas liquids (NGLs). The company’s operations are concentrated in two main areas namely the Mid-Continent region consisting …
  • Enable Injections Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enable Injections Inc (Enable Injections) is a medical device company that manufactures and develops disposable body-worn bolus injector to deliver high viscosity payloads to the subcutaneous tissue. The company develops delivery device, delivery systems, and injector systems including vial …
  • Micro Labs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • ConSynance Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics) is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company’s pipeline programs include CSTI-100, CSTI-200, and CSTI-300 among others. It develops pipeline programs fo …
  • VION N.V.:企業の戦略・SWOT・財務情報
    VION N.V. - Strategy, SWOT and Corporate Finance Report Summary VION N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • TransGenic Inc (2342):企業の財務・戦略的SWOT分析
    TransGenic Inc (2342) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Tengasco Inc (Tengasco) is an oil and gas exploration and production company that offers oil and gas development and exploration services. The company acquires, explores, produces, extracts, operates, m …
  • Bertelsmann SE & Co KgaA:企業の戦略的SWOT分析
    Bertelsmann SE & Co KgaA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …
  • Minnetronix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Minnetronix Inc (Minnetronix) is a medical device company that offers medical system integrators. The company designs electronic and electromechanical systems. It offers products such as intraperitoneal heating and fluids control, brain stimulation system, 3-D imaging for ear canal measureme …
  • QUALCOMM Incorporated:企業の戦略・SWOT・財務情報
    QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report Summary QUALCOMM Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SPX Corporation:企業の戦略・SWOT・財務情報
    SPX Corporation - Strategy, SWOT and Corporate Finance Report Summary SPX Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SPIE Nucleaire:企業の戦略的SWOT分析
    SPIE Nucleaire - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Yasuhara Chemical Co Ltd (4957):企業の財務・戦略的SWOT分析
    Yasuhara Chemical Co Ltd (4957) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Nikkei Inc.:企業の戦略的SWOT分析
    Nikkei Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Cadence Design Systems, Inc.:企業の戦略・SWOT・財務情報
    Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Cadence Design Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CNA Financial Corporation:企業の戦略・SWOT・財務情報
    CNA Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary CNA Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • J.M. Huber Corp:企業の戦略的SWOT分析
    J.M. Huber Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Power Assets Holdings Limited (6):石油・ガス:M&Aディール及び事業提携情報
    Summary Power Assets Holdings Limited (Power Assets) a subsidiary of CK Infrastructure Holdings Limited, is an investment holding company. The company through its subsidiaries, joint ventures, and affiliates, invests in power and utility-related businesses. The company has interests in electricity g …
  • Guangzhou Pharmaceuticals Corp:企業の戦略的SWOT分析
    Guangzhou Pharmaceuticals Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆